Cryolife (CRY) EPS Estimated At $0.11, Horizon Pharma Plc Ord Ireland (HZNP) Shorts Lowered By 11.19%

June 20, 2017 - By Winifred Garcia

Analysts expect Cryolife Inc (NYSE:CRY) to report $0.11 EPS on July, 24.They anticipate $0.02 EPS change or 15.38% from last quarter’s $0.13 EPS. CRY’s profit would be $3.67 million giving it 42.39 P/E if the $0.11 EPS is correct. After having $0.09 EPS previously, Cryolife Inc’s analysts see 22.22% EPS growth. The stock increased 0.81% or $0.15 during the last trading session, reaching $18.65. About shares traded. Cryolife Inc (NYSE:CRY) has risen 60.65% since June 20, 2016 and is uptrending. It has outperformed by 43.95% the S&P500.

Horizon Pharma Plc Ord Ireland (NASDAQ:HZNP) had a decrease of 11.19% in short interest. HZNP’s SI was 12.06M shares in June as released by FINRA. Its down 11.19% from 13.57M shares previously. With 8.03M avg volume, 2 days are for Horizon Pharma Plc Ord Ireland (NASDAQ:HZNP)’s short sellers to cover HZNP’s short positions. The SI to Horizon Pharma Plc Ord Ireland’s float is 7.94%. The stock increased 3.98% or $0.41 during the last trading session, reaching $10.7. About shares traded. Horizon Pharma PLC (NASDAQ:HZNP) has declined 28.13% since June 20, 2016 and is downtrending. It has underperformed by 44.83% the S&P500.

Among 10 analysts covering Horizon Pharma (NASDAQ:HZNP), 6 have Buy rating, 0 Sell and 4 Hold. Therefore 60% are positive. Horizon Pharma had 26 analyst reports since September 9, 2015 according to SRatingsIntel. The firm has “Buy” rating by Goldman Sachs given on Monday, June 6. The firm has “Outperform” rating given on Wednesday, June 29 by BMO Capital Markets. Morgan Stanley reinitiated Horizon Pharma PLC (NASDAQ:HZNP) rating on Thursday, December 3. Morgan Stanley has “Underweight” rating and $23.0 target. The stock has “Buy” rating by Mizuho on Friday, December 16. Mizuho maintained it with “Buy” rating and $33 target in Tuesday, September 13 report. On Friday, September 16 the stock rating was downgraded by Cowen & Co to “Market Perform”. The company was initiated on Thursday, December 17 by Goldman Sachs. As per Wednesday, January 6, the company rating was reinitiated by Citigroup. The firm has “Mkt Outperform” rating given on Wednesday, September 9 by JMP Securities. The rating was downgraded by Mizuho on Friday, December 9 to “Neutral”.

Since February 28, 2017, it had 1 insider buy, and 1 insider sale for $414,996 activity. $94,800 worth of Horizon Pharma PLC (NASDAQ:HZNP) was bought by GREY MICHAEL G. 31,808 shares were sold by Carey Robert, worth $509,796.

Investors sentiment decreased to 1.02 in 2016 Q4. Its down 0.44, from 1.46 in 2016Q3. It fall, as 40 investors sold Horizon Pharma PLC shares while 69 reduced holdings. 44 funds opened positions while 67 raised stakes. 134.44 million shares or 0.39% more from 133.91 million shares in 2016Q3 were reported. Systematic Financial Mgmt Lp invested in 0.06% or 218,495 shares. Moody National Bank & Trust Division stated it has 0.01% of its portfolio in Horizon Pharma PLC (NASDAQ:HZNP). Quantbot Techs Limited Partnership reported 0.07% of its portfolio in Horizon Pharma PLC (NASDAQ:HZNP). Moreover, Hl Fincl Services Lc has 0.01% invested in Horizon Pharma PLC (NASDAQ:HZNP) for 20,900 shares. Next Fin Group Inc has 0% invested in Horizon Pharma PLC (NASDAQ:HZNP) for 100 shares. Fmr Limited Liability Corporation reported 5.70 million shares or 0.01% of all its holdings. Silvercrest Asset Mngmt Group Inc Ltd Liability Com reported 11,560 shares. Millennium Mgmt Limited Company reported 66,569 shares stake. Alps Advsrs accumulated 154,966 shares or 0.02% of the stock. Envestnet Asset Incorporated holds 0.01% of its portfolio in Horizon Pharma PLC (NASDAQ:HZNP) for 120,714 shares. Paloma Prns Mngmt reported 28,571 shares or 0% of all its holdings. Aqr Cap Mngmt Ltd Liability stated it has 18,541 shares. Ubs Asset Mgmt Americas Inc holds 0% or 244,533 shares. Ahl Ltd Liability Partnership reported 59,773 shares. Ameritas Inv Partners Incorporated reported 13,933 shares.

Horizon Pharma Public Limited Company is a biopharmaceutical company. The company has market cap of $1.67 billion. The Firm is focused on identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. It currently has negative earnings. As of December 31, 2016, the Company marketed 11 medicines through its orphan, rheumatology and primary care business units.

Among 4 analysts covering Cryolife (NYSE:CRY), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Cryolife had 5 analyst reports since April 13, 2016 according to SRatingsIntel. The stock of Cryolife Inc (NYSE:CRY) earned “Buy” rating by Northland Capital on Monday, May 1. Northland Capital initiated the stock with “Outperform” rating in Monday, January 9 report. The rating was initiated by Lake Street on Wednesday, June 15 with “Buy”. The rating was initiated by Canaccord Genuity on Wednesday, April 13 with “Buy”. The rating was upgraded by Ladenburg Thalmann on Friday, February 17 to “Buy”.

CryoLife, Inc. is a medical device maker and processor, and is engaged in the distribution of medical devices and implantable human tissues used in cardiac surgical procedures. The company has market cap of $621.99 million. The Firm operates through two divisions: Medical Devices and Preservation Services. It has a 60.51 P/E ratio. The Medical Devices segment includes medical devices, such as BioGlue Surgical Adhesive, BioFoam Surgical Matrix, On-X Life Technologies Holdings, Inc. valves and surgical products, CardioGenesis cardiac laser therapy product line, PerClot and PhotoFix.

Investors sentiment decreased to 1.41 in Q4 2016. Its down 0.17, from 1.58 in 2016Q3. It dropped, as 13 investors sold Cryolife Inc shares while 38 reduced holdings. 28 funds opened positions while 44 raised stakes. 22.02 million shares or 2.38% more from 21.51 million shares in 2016Q3 were reported. Capstone Asset invested in 0.01% or 12,060 shares. Eam Invsts Lc holds 50,514 shares or 0.13% of its portfolio. Pier Ltd Liability Co accumulated 303,668 shares. Arizona State Retirement Sys invested 0% of its portfolio in Cryolife Inc (NYSE:CRY). Vanguard Group Inc stated it has 0% in Cryolife Inc (NYSE:CRY). State Of Tennessee Treasury Department, Tennessee-based fund reported 20,073 shares. Renaissance Technologies Ltd Llc has 527,000 shares for 0.02% of their portfolio. Geode Capital Mgmt Ltd invested in 201,387 shares. Credit Suisse Ag holds 46,069 shares. Pinebridge Investments L P stated it has 0% of its portfolio in Cryolife Inc (NYSE:CRY). 104,299 were accumulated by Royal Comml Bank Of Canada. Bnp Paribas Arbitrage reported 0% of its portfolio in Cryolife Inc (NYSE:CRY). New York State Common Retirement Fund reported 32,300 shares. Friess Associates Limited Liability Com stated it has 40,000 shares or 0.08% of all its holdings. California Employees Retirement System holds 0% or 112,300 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: